Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has received approval from China’s National Medical ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Alembic Pharmaceuticals stated that it gained final FDA approval for the Diltiazem Hydrochloride Extended-Release capsules, ...

Alembic has a cumulative total of 218 ANDA approvals (191 final approvals and 27 tentative approvals) from USFDA, it added.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

SMC Global said thay UBL remains committed to growth in the beer category, aiming to capture a wide range of market segments ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

Zealand Pharma A/S briefly reclaimed its position as this year’s best performer in the Stoxx 600 Health Care Index on Friday, ...

Alembic Pharmaceuticals Limited announced today it has received final approval from the US Food & Drug Administration (USFDA) ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

Aurobindo Pharma Ltd is quoting at Rs 1265.85, down 4.65% on the day as on 12:59 IST on the NSE. The stock jumped 29.25% in last one year as compared to a 24.11% rally in NIFTY and a 43.47% spurt in ...

These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering a generic alternative to ...